| # | Drug | Count |
|---|---|---|
| 0 | TADALAFIL | 5 |
| 1 | AMBRISENTAN | 4 |
| 2 | BOSENTAN | 4 |
| 3 | MACITENTAN | 4 |
| 4 | ATORVASTATIN CALCIUM | 3 |
| 5 | LACOSAMIDE | 3 |
| 6 | LORAZEPAM | 3 |
| 7 | ALBUTEROL SULFATE | 2 |
| 8 | ATROPINE INJECTION, 2 MG | 2 |
| 9 | ATROPINE SULFATE INJECTION USP, 0.5 MG/0.7 ML | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATROPINE INJECTION, 2 MG | 2 | 0.0013 |
| 1 | TAURINE | 1 | 0.0013 |
| 2 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 3 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0004 |
| 4 | CODEINE SULFATE | 1 | 0.0003 |
| 5 | BACITRACIN | 1 | 0.0003 |
| 6 | ACARBOSE | 1 | 0.0003 |
| 7 | ELOSULFASE ALFA | 1 | 0.0002 |
| 8 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 | 0.0002 |
| 9 | BUROSUMAB | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Anticholinergic [EPC] | 2 | 0.0001 |
| 2 | Barbiturate [EPC] | 1 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Cholinergic Muscarinic Antagonist [EPC] | 2 | 0.0001 |
| 5 | Endothelin Receptor Antagonist [EPC] | 8 | 0.0000 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 5 | 0.0000 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 2 | 0.0000 |